|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.72 USD | -2.73% |
|
-2.22% | -21.02% |
| Nov. 18 | Airsculpt Technologies, Inc. Appoints Mike Doyle as Non-Executive Chairman of the Board | CI |
| Nov. 17 | AirSculpt Names Mike Doyle as Non-Executive Chairman | MT |
| Capitalization | 2.15B 1.85B 1.74B 1.61B 2.97B 194B 3.24B 20.22B 7.83B 91.42B 8.06B 7.89B 335B | P/E ratio 2025 * |
-53.7x | P/E ratio 2026 * | 59x |
|---|---|---|---|---|---|
| Enterprise value | 5.55B 4.77B 4.48B 4.17B 7.68B 500B 8.38B 52.23B 20.22B 236B 20.81B 20.37B 865B | EV / Sales 2025 * |
1.69x | EV / Sales 2026 * | 1.58x |
| Free-Float |
59.59% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Surgery Partners, Inc.
| 1 day | -2.73% | ||
| 1 week | -2.22% | ||
| Current month | -2.05% | ||
| 1 month | -22.23% | ||
| 3 months | -24.28% | ||
| 6 months | -27.90% | ||
| Current year | -21.02% |
| 1 week | 16.61 | 17.44 | |
| 1 month | 14.94 | 18.46 | |
| Current year | 14.94 | 26.16 | |
| 1 year | 14.94 | 26.16 | |
| 3 years | 14.94 | 45.79 | |
| 5 years | 14.94 | 69.58 | |
| 10 years | 4 | 69.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Evans
CEO | Chief Executive Officer | 48 | 2020-01-12 |
David Doherty
DFI | Director of Finance/CFO | 52 | 2022-01-31 |
Varun Gadhok
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Turner
BRD | Director/Board Member | 59 | 2015-12-29 |
Teresa Deluca
BRD | Director/Board Member | 60 | 2016-09-29 |
T. O'Reilly
CHM | Chairman | 50 | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.73% | -2.22% | -23.62% | -37.35% | 2.15B | ||
| +0.24% | +2.03% | +14.96% | +42.17% | 18.27B | ||
| +0.88% | -1.47% | -22.76% | -48.98% | 14.99B | ||
| -0.07% | -2.09% | -1.43% | +51.35% | 11.32B | ||
| -0.52% | -2.43% | +9.18% | +96.33% | 11.26B | ||
| -1.45% | -4.49% | +21.60% | +87.36% | 10.09B | ||
| +0.53% | -0.53% | -25.88% | -33.10% | 9.41B | ||
| 0.00% | +3.47% | -18.04% | - | 8.11B | ||
| +0.35% | -5.67% | +20.05% | +202.36% | 7.21B | ||
| -0.25% | -5.22% | -9.73% | -45.95% | 5.43B | ||
| Average | -0.30% | -1.46% | -3.57% | +34.91% | 9.82B | |
| Weighted average by Cap. | -0.03% | -1.10% | -1.14% | +37.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.29B 2.83B 2.66B 2.47B 4.56B 297B 4.97B 30.98B 12B 140B 12.35B 12.08B 513B | 3.56B 3.07B 2.88B 2.68B 4.93B 321B 5.38B 33.54B 12.99B 152B 13.37B 13.08B 555B |
| Net income | -37.31M -32.12M -30.15M -28.03M -51.66M -3.36B -56.36M -351M -136M -1.59B -140M -137M -5.82B | 49.79M 42.85M 40.23M 37.4M 68.93M 4.49B 75.21M 469M 182M 2.12B 187M 183M 7.76B |
| Net Debt | 3.4B 2.93B 2.75B 2.55B 4.71B 306B 5.13B 32B 12.39B 145B 12.75B 12.48B 530B | 3.49B 3.01B 2.82B 2.62B 4.84B 315B 5.28B 32.9B 12.74B 149B 13.11B 12.83B 545B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-08 | 16.72 $ | -2.73% | 3,147,878 |
| 25-12-05 | 17.19 $ | -1.09% | 1,574,412 |
| 25-12-04 | 17.38 $ | +2.00% | 883,229 |
| 25-12-03 | 17.04 $ | +1.67% | 1,422,873 |
| 25-12-02 | 16.76 $ | -1.99% | 1,132,887 |
Delayed Quote Nasdaq, December 08, 2025 at 04:00 pm EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SGRY Stock
Select your edition
All financial news and data tailored to specific country editions
















